About us

IndiCell is run as a multi-stakeholder project, involving academia, industry and healthcare.


Who are we?

IndiCell is a collaboration between academia (LU, KI, KTH), industry (BioLamina, AcouSort, MAGic BioProcessing) and healthcare (SUS, Karolinska).

Scientific project leader: Anna Falk (LU)

Administrative Project Manager: Paulina Pettersson (LU)

Anna Falk, Scientific Project Leader (LU) Photo: Charlotte Carlberg Barg

Paulina Pettersson, Administrative Project Manager (LU)

Almost the entire IndiCell team gathered in Lund for a two-day meeting with in-depth discussions and collaboration between the work packages (WP 1-6).


Responsibilities and roles

Lund University

Is the coordinator for the whole project and involved in all work packages (WP).

Karolinska Institutet

Co-coordinator of the project and involved in work packages 1, 3, 4 & 6.

Royal Institute of Technology

Is mainly involved in the work package Reprogramming-in-a-chip (WP2) and Project Management (WP6).


Involved in particular in the work packages Reprogramming-in-a-chip (WP2) and Innovation (WP5), as well as Project Management (WP6).


Is mainly involved in the work package Cell Procurement (WP1) and Project Management (WP6).

MAGic BioProcessing

Is mainly involved in the work package Cell Sorting (WP3) and Project Management (WP6).

Skåne University Hospital

Is mainly involved in the work package Cell Procurement (WP1) as well as Innovation (WP5) and Project Management (WP6).

Karolinska University Hospital

Involved in all work packages, apart from Innovation (WP5).

Distinguished roles

Coordinating profiles

Professor Anna Falk

Anna is the project’s scientific project manager. She is Professor of Neural Stem Cells at Lund University. Her lab has developed a hiPSC line in the GMP facility Vecura, Stockholm, Sweden.

Anna coordinates the project in collaboration with Malin and Fredrik.

Professor Malin Parmar

Malin is Professor of Developmental and Regenerative Neurobiology at Lund University and Robertson Investigator at the New York Stem Cell Foundation. Her lab has developed the method for manufacturing hPSC-derived dopaminergic neuron progenitors for the treatment of Parkinson’s disease. The product is manufactured at the Royal Free Hospital, London, UK.

Bitr. Prof. Fredrik Lanner

Fredrik is an associate professor at Karolinska Institutet. His lab has developed the method for manufacturing hPSC-derived retinal pigment epithelium for the treatment of dry age-related macular degeneration. The product is manufactured by Fredrik’s staff at Vecura, Stockholm, Sweden and is Sweden’s first hPSC-ATMP.